Company · founded 2003

NovoBiotic Pharmaceuticals

Cambridge, United States · novobiotic.com

Manage this page

Citations, last 5 years: 386
Works, last 5 years: 8
h-index: 44
Scientists listed: 2
Grants since 2016: 27

Grants received

2023–2025 · research · R43

Antifungal discovery from previously uncultivated bacteria

Amy Lynn Spoering · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$295.8k

2023–2025 · research · R43

Antifungal discovery from previously uncultivated bacteria

Amy Lynn Spoering · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$300k

2022–2025 · research · R44

Teixobactin Development for Tuberculosis

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$992.5k

2022–2025 · research · R44

Teixobactin Development for Tuberculosis

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$996.3k

2022–2025 · research · R44

Teixobactin Development for Tuberculosis

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1,000k

2021–2026 · research · R01

Developing Teixobactin for Respiratory Infections

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1.2M

2021–2026 · research · R01

Developing Teixobactin for Respiratory Infections

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1.1M

2021–2026 · research · R01

Developing Teixobactin for Respiratory Infections

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1.2M

2021–2026 · research · R01

Developing Teixobactin for Respiratory Infections

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1.5M

2021–2027 · research · R01

Developing Teixobactin for Respiratory Infections

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1.1M

2020–2022 · research · R43

Antibiotic discovery from a new genus of uncultured bacteria.

Amy Lynn Spoering · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$296.5k

2020–2024 · research · R44

Teixobactin Development for Anthrax

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$992.8k

2020–2023 · research · R44

Teixobactin Development for Anthrax

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$996.4k

2020–2023 · research · R44

Teixobactin Development for Anthrax

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1,000k

2020–2022 · research · R43

Antibiotic discovery from a new genus of uncultured bacteria.

Amy Lynn Spoering · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$299.5k

2018 · research · R43

Preclinical development of Novo29, a new antibiotic

Losee Lucy Ling · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$231.4k

2018–2022 · research · R44

Preclinical development of Novo29, a new antibiotic

Losee Lucy Ling · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$987.4k

2018–2023 · research · R44

Preclinical development of Novo29, a new antibiotic

Losee Lucy Ling · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$977.5k

2018–2022 · research · R44

Preclinical development of Novo29, a new antibiotic

Losee Lucy Ling · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$1,000k

2017–2019 · research · R43

Novel Antibiotics from Marine Invertebrate Microbes

Amy Lynn Spoering · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$300kMicrobial Natural Products and Biosynthesis

2017–2019 · research · R43

Novel Antibiotics from Marine Invertebrate Microbes

Amy Lynn Spoering · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$286.2kMicrobial Natural Products and Biosynthesis

2016–2019 · research · R44

Exploratory Chemistry on a new antibiotic

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$738.4k

2016–2018 · research · R44

Exploratory Chemistry on a new antibiotic

Dallas Hughes · NovoBiotic Pharmaceuticals · funded by National Institutes of Health

$746.2k

2016–2017 · research · Global Health